
Denton City Council repealed a cannabis decriminalization ordinance, Proposition B, potentially from growing pressure from Texas Attorney General Ken Paxton.

Denton City Council repealed a cannabis decriminalization ordinance, Proposition B, potentially from growing pressure from Texas Attorney General Ken Paxton.

As Texas advances legislation to ban hemp-derived THC, HB 46 seeks to expand the state’s medical cannabis program, with several recent changes.

First cannabis dispensary outside of Tribal lands opened by White Earth Nation in Minnesota.

Nearly halfway through 2025, let’s revisit what new scientific updates and insights have been happening in the industry.

Most military veterans and their family members felt that the Department of Veterans Affairs should be offering medical cannabis as a treatment option.

Here, we bring you our top five recent articles covering hemp restrictions in Alabama and Texas, data on medical cannabis patients and sleep apnea, FDA making psychedelics a top priority, and research on cannabis use and sperm quality.

The city of Albuquerque, New Mexico is officially introducing their basic income pilot program which will help communities impacted by cannabis criminalization.

Industry stakeholders responded to the bill, which would prohibit the sale and possession of hemp-derived THC, among other restrictions.

In this interview clip from our Women in Grow: Leadership in Cannabis Genetics and Cultivation supplement, Anna Schwabe, PhD explains her research on variations in cannabis genetics and their significance.

New legislation signed into law by Minnesota Governor Tim Walz, ends criminal penalties related to bong water.

Researchers analyzed data from 262 counties, identifying sociodemographic characterizations, associations, and discrepancies.

A recent study investigated whether cannabis use plays a role in sperm quality.

The report includes data from enrolled patients on products purchased, benefits, and side effects.

FDA Commissioner, Dr. Marty Makary, under the Trump Administration, announced in a recent interview that the government agency is making psychedelics a top priority.

The study also identified a new cannabinoid in the plant, named cannabielsoxa.

Alabama Governor Kay Ivey recently signed into law HB 445, a hemp restriction bill that has received opposition from the hemp industry.

Here, we bring you our top five recent articles covering cannabis legalization bills in Pennsylvania and Virginia, hemp regulation compliance in California, the first map of tribal cannabis and hemp programs, and a study on cannabis consumption and a sedentary lifestyle.

Curaleaf International and Jupiter Research LLC, announce the first liquid inhalation device has received an EU medical device certification.

The first-of-its-kind survey from ASTM International aims to build a cannabis and hemp standards roadmap for 2030.

The Pennsylvania Senate rejected a bill that would have legalized adult-use cannabis in the state.

The Indigenous Cannabis Industry Association (ICIA) and Vicente LLP recently released the first-ever comprehensive map of Tribal cannabis and hemp programs.

The study examined data from nearly 20,000 individuals and found no link between cannabis users and non-users and levels of physical activity.

Congresswoman Dina Titus and Congresswoman Ilhan Omar recently introduced the Evidence-Based Drug Policy Act of 2025 to Congress, which hopes to change restrictions on cannabis research.

A recent study highlighted potential benefits for CBD to provide relief from chronic pain.

The survey asked about patient cannabis use, openness to discussing cannabis as part of treatment plans, and perspectives on substance use of physicians.

The Pennsylvania House recently approved HB 1200, a cannabis legalization bill that could legalize adult-use cannabis in the state.

The emergency regulations, effective in September 2024, prohibit hemp products in California to contain any THC.

Virginia Governor Youngkin recently vetoed HB 1989, a medical cannabis bill which would have made improvements to medical cannabis access and product labeling.

The US Supreme Court declined to hear a case regarding a ban on medical cannabis advertising in Mississippi.

The large-scale analysis focused on the language of the studies to establish positive, negative, or neutral associations with cannabis and cancer.